News | Treatment Planning | March 10, 2021

Together the companies will increase radiological report automation through AI and Anatomical Mapping and will create unparalleled longitudinal data

Stefan Vilsmeier Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research

Stefan Vilsmeier, President and CEO, Brainlab


March 10, 2021 — Brainlab announced the acquisition of Mint Medical GmbH, a Heidelberg-based company that develops image reading and reporting software for clinical routine and research. The acquisition underscores the Brainlab commitment to digital health and aims to improve the structured diagnosis, analysis and treatment of cancer and other diseases to address the demands of modern medicine and personalized treatments.

Mint Medical facilitates the diagnostic process: While working through an image exam, the radiologist is supported in capturing all primary and secondary information that is relevant to the patient’s diagnosis and therapeutic decision making. The technology-enabled, context-sensitive way of radiological reporting bridges the gap between the image and the diagnostic report, yielding a structured, yet holistic view on the individual patient’s situation and clinical history.

“The transformation of our health care system is currently focused in large part on standardizing clinical data through a coding system,” commented Stefan Vilsmeier, President and CEO, Brainlab. “However, high quality and consistency of such data requires a validated, reproducible, and structured digital process, for which Mint Medical is setting the benchmark.”

Together, market leading software-based Brainlab and Mint technologies will offer existing Mint customers the ability to link data across multiple oncological subspecialties, from clinical oncology to surgical oncology and radiotherapy. Integrating patient-reported outcomes measures (PROMs) from VisionTree, a Brainlab company, will further add valuable longitudinal data to the pool available for analysis.

Mint Medical radiology users will additionally benefit from Brainlab expertise in deep integration with a broad spectrum of standards (DICOM, FHIR, HL7) and within hospital information systems (HIS). Users will benefit from further process automation by extracting pre-existing data to prefill certain fields in the structured clinical forms. Further automation will be achieved by adding Brainlab Anatomical Mapping and context-based AI algorithms to automatically extract information from diagnostic images, more efficiently linking image data with the structured templates.

“Brainlab brings to Mint a highly compatible entrepreneurial culture, enabling us to more rapidly enhance, scale, and deploy our technology,” commented Matthias Baumhauer, President of Mint Medical. “We are excited about the tremendous opportunities for both our clinical research and clinical routine users.”

The acquisition bolsters the Brainlab oncology portfolio by frontloading the treatment planning process with more detailed, structured, and clinically relevant information. During tumor board meetings, participants will gain access to standardized reports on radiological findings to support their discussion on patient-specific treatment decisions. Post-treatment, integrating data from oncology and radiology will enhance the follow-up process through a systematic response assessment. In addition to oncology, other subspecialties like spine surgery will benefit from the technology. Structured radiological reports will allow software-driven comparison and therefore independent validation through multiple experts either in the context of a clinical trial or for quality assurance.

Mint Medical clinical trial users will benefit from Brainlab technology for cloud computing, image data analysis, and patient-reported outcomes measures, putting the patient at the center. Brainlab and Mint Medical aim to jointly improve the technological infrastructure for managing clinical trials as well as large scale registries.

For more information: www.brainlab.com

Related Content

News | Radiation Therapy

June 24, 2022 — Recently, a collaborated research team led by Prof. LI Hai and Hongzhi Wang from Hefei Institutes of ...

Time June 24, 2022
arrow
News | Radiation Therapy

June 23, 2022 — RaySearch Laboratories AB announced the release of the latest version of RayCare*, the next generation ...

Time June 23, 2022
arrow
News | Radiation Therapy

June 17, 2022 — Accuray Incorporated and Limbus AI Inc. announced they are partnering to augment Accuray adaptive ...

Time June 17, 2022
arrow
News | Prostate Cancer

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

Time June 10, 2022
arrow
Feature

Imaging Technology News (ITN) maintains more than 40 comparison charts of product specifications from various vendors ...

Time June 09, 2022
arrow
News | Digital Pathology

June 8, 2022 — Proscia, a leader in digital and computational pathology solutions, announced that its Concentriq Dx ...

Time June 08, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Radiation Therapy

June 3, 2022 — Henry Ford Health is the first in the world to complete a full course of patient treatments using the ...

Time June 03, 2022
arrow
News | ASTRO

June 2, 2022 — The American Society for Radiation Oncology (ASTRO) recently hired Chris Neumann as its new Vice ...

Time June 02, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
Subscribe Now